Pathway Bio
PrivateLast Round
Pre Seed
Oct 13, 2025
Total Funding Raised
$350,000
Company Overview
Pathway Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Pre Seed round in October 2025.
Pathway Bio is a healthtech company that provides a functional precision medicine platform to predict and validate cancer treatment outcomes using multiomic profiling, AI-driven prediction, and ex vivo microcancer technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathway Bio Comparables
Compare Pathway Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deep Origin | 81% | |
| AI Vivo | 77% | |
| Insilico Medicine | 76% |
For institutional investors. Book with your work email.
Pathway Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 13, 2025 | ||||
| Accelerator | Jan 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pathway Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Accelerator |
| LifeArc | Accelerator |
| Cancer Research Horizons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
$50K raised from LifeArc, Cancer Research Horizons, and KQ Labs.
For institutional investors. Book with your work email.
Pathway Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pathway Bio's valuation, stock price, and market status.
Is Pathway Bio a public or private company?
Pathway Bio is a private company.
What is the current stock price of Pathway Bio?
Pathway Bio is a private company, so its shares have no public market price. Caplight tracks Pathway Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pathway Bio worth (valuation)?
Valuation information for Pathway Bio is not publicly available.
Can I buy Pathway Bio stock?
Pathway Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pathway Bio's last funding round?
Pathway Bio's most recent funding round was Pre Seed on October 13, 2025.
Who are the main investors in Pathway Bio?
Key investors in Pathway Bio include KQ Labs, LifeArc, Cancer Research Horizons.
Will Pathway Bio IPO soon?
No public IPO plans have been announced for Pathway Bio.
How can I track Pathway Bio secondary market activity?
Caplight tracks bids, offers, and trades in Pathway Bio's shares on secondary markets.